
Early Ophthalmological Manifestations of Acute Myeloid Leukemia: Current Perspectives
Author(s) -
Nasrine Anais El Salloukh,
Dany Hage,
Anna Z Bashshur,
Wajiha Jurdi Kheir
Publication year - 2022
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s342720
Subject(s) - medicine , myeloid leukemia , malignancy , leukemia , myeloid , myeloid sarcoma , disease , pathology , acute leukemia , immunology
Acute myeloid leukemia (AML) is a hematological malignancy affecting different organ systems including the eye. The purpose of this review is to present and evaluate the medical literature regarding the early ophthalmological manifestations of acute myeloid leukemia. AML affects the ocular system through direct infiltration of tissues, secondary to hematological abnormalities, or in the form of chloroma or myeloid sarcoma in the brain or orbit consequently leading to a variety of manifestations depending on the ocular tissue involved. It is imperative for ophthalmologists to be aware of the early ophthalmological manifestations of AML which will allow for earlier diagnosis and treatment of this life-threatening disease.